IL19 and chronic obstructive pulmonary disease: Bronchial epithelial cells from asthma and COPD patients express large amounts of IL-19, which is involved in allergic airway inflammation through the activation of group 2 innate lymphocytes (ILC2, 15] and induction of Th2-dominant immune response disorder [27].